Egészség01 szeptember, 2021

Lippincott portfolio of journals sees sweeping impact factor gains

Wolters Kluwer, Health announced today that three of its Lippincott journals have been ranked #1 based on their 2020 Journal Citation Report (JCR) Impact Factor Score from Clarivate Analytics. An Impact Factor (IF) is a measurement of the frequency by which an article in a scholarly journal is cited in a particular year. Of the 210 Lippincott titles listed in the JCR rankings, 88% had Impact Factor gains over the previous year, with 98 journals increasing by 25% or more.

Lippincott holds 17 Top 5 rankings across 13 specialties and 36 Top 10 rankings across 27 specialties. Rounding out the top 20 rankings, Lippincott holds 77 spots across 50 specialties.

Lippincott publishes the top-ranked titles in the following subject categories:

  • Audiology & Speech-Language Pathology: Ear & Hearing (IF 3.570), the official journal of the American Auditory Society
  • Education, Scientific Disciplines: Academic Medicine (IF 6.893), the official journal of the Association of American Medical Colleges
  • Peripheral & Vascular Disease: Circulation (IF 29.690), published on behalf of the American Heart Association

Lippincott publishes Top 10 titles in the following categories:

Anatomy & Morphology

  • #10 Applied Immunohistochemistry & Molecular Morphology (IF 2.085), the official publication of the International Society for Immunohistochemistry & Molecular Morphology

Anesthesiology

  • #3 Anesthesiology (IF 7.892), published on behalf of the American Society of Anesthesiologists
  • #4 Pain (IF 6.961), published on behalf of the International Association for the Study of Pain
  • #7 Anesthesia & Analgesia (IF 5.108), published on behalf of the International Anesthesia Research Society
  • #10 European Journal of Anaesthesiology (IF 4.330), published on behalf of the European Society of Anaesthesiology

Cardiac & Cardiovascular Systems

  • #3 Circulation (IF 29.690), published on behalf of the American Heart Association
  • #5 Circulation Research (IF 17.367), published on behalf of the American Heart Association

Critical Care Medicine

  • #4 Critical Care Medicine (IF 7.598), published in conjunction with the Society of Critical Care Medicine

Emergency Medicine

  • #10 European Journal of Emergency Medicine (IF 2.799), the official journal of the European Society for Emergency Medicine

Gastroenterology & Hepatology

  • #9 American Journal of Gastroenterology (IF 10.864), the official journal of the American College of Gastroenterology

Healthcare Sciences & Services

  • #4 Academic Medicine (IF 6.893), the official journal of the Association of American Medical Colleges

Hematology

  • #4 Circulation Research (IF 17.367), published on behalf of the American Heart Association
  • #9 Arteriosclerosis, Thrombosis, and Vascular Biology (IF 8.311), published on the behalf of the American Heart Association

Medical, Laboratory & Technology

  • #9 Therapeutic Drug Monitoring (IF 3.681), Official Journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Obstetrics & Gynecology

  • #3 Obstetrics & Gynecology (IF 7.661), published on behalf of the American College of Obstetricians and Gynecologists

Oncology

  • #4 Journal of Clinical Oncology (IF 44.544), published on behalf of the American Society of Clinical Oncology

Ophthalmology

  • #10 RETINA-The Journal of Retinal and Vitreous Diseases (IF 4.256)

Orthopaedics

  • #5 The Journal of Bone & Joint Surgery (IF 5.284)

Otorhinolaryngology

  • #4 Ear & Hearing (IF 3.570), the official title of the American Auditory Society

Pathology

  • #9 American Journal of Surgical Pathology (IF 6.394), affiliated with The Arthur Purdy Stout Society of Surgical Pathologists and The Gastrointestinal Pathology Society

Physiology

  • #9 Exercise and Sport Sciences Reviews (IF 4.915), published on behalf of the American College of Sports Medicine

Peripheral Vascular Disease

  • #2 Circulation Research (IF 17.367), published on behalf of the American Heart Association
  • #3 Hypertension (IF 10.190), published on behalf of the American Heart Association
  • #5 Arteriosclerosis, Thrombosis & Vascular Biology (IF 8.311), published on behalf of the American Heart Association
  • #6 Stroke (IF 7.914), published on behalf of the American Heart Association

Radiology

  • #8 Clinical Nuclear Medicine (IF 7.794)

Rehabilitation

  • #8 Journal of Neurologic Physical Therapy (IF 3.649), the official journal of the Academy of Neurologic Physical Therapy

Sport Sciences

  • #6 Exercise and Sport Sciences Review (IF 6.230), published on behalf of the American College of Sports Medicine
  • #8 Medicine & Science in Sports & Exercise (IF 5.411), published on behalf of the American College of Sports Medicine

Substance Abuse

  • #10 Journal of Addiction Medicine (IF 3.702), the official journal of the American Society of Addiction Medicine

Surgery

  • #2 Annals of Surgery (IF 12.969), affiliated with the American Surgical Association and the European Surgical Association

Transplantation

  • #7 Transplantation (IF 4.939), the official journal of The Transplantation Society

Urology & Nephrology

  • #10 Journal of Urology (IF 7.450), the official journal of the American Urological Association

Highlights for Wolters Kluwer’s Medknow titles include:

  • 32 titles listed in JCR rankings in 2020
  • 75% of titles had Impact Factor gains over the previous year
  • Asia-Pacific Journal of Oncology Nursing received its first Impact Factor score in 2020
  • Endoscopic Ultrasound (IF 5.628) received the highest score for the portfolio
  • Neurological Sciences and Neurophysiology saw a 293% increase in its Impact Factor

For more information on the Lippincott portfolio of journals from Wolters Kluwer, visit lww.com.

A Wolters Kluwer vállalatról

Wolters Kluwer (EURONEXT: WKL) globális vezető szerepet tölt be az információk, szoftvermegoldások és szolgáltatások terén a professzionális egészségügyi, az adó- és számviteli, a pénzügyi és vállalati megfelelés, a jogi és szabályozási, valamint a vállalati teljesítmény és az ESG üzletágak számára. Segítünk ügyfeleinknek a mindennapi kritikus döntések meghozatalában, melyhez olyan profi megoldásokat nyújtunk, amelyek technológiával és szolgáltatásokkal egyesítik a megalapozott birtokolt ismereteket.

Back To Top